| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:1623-1629.)
© 2004 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Division of Preventive Medicine, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School (P.J.M., J.E.M., H.D.S., C.M.A., M.J.C., N.R.C., P.G., P.M.R., R.J.G.), Boston, Mass, and the Department of Preventive Medicine, Northwestern University Medical School (P.G.), Chicago, Ill.
Correspondence to Robert J. Glynn, ScD, Brigham and Womens Hospital, Division of Preventive Medicine, 900 Commonwealth Ave E, Boston, MA 02215-1204. E-mail rglynn{at}rics.bwh.harvard.edu
Received June 21, 2001; de novo received October 16, 2003; revision received January 5, 2004; accepted January 14, 2004.
Background In apparently healthy people, the relation between blood pressure and risk of subsequent cardiovascular disease (CVD) is linear. In persons with CVD, the relation is uncertain.
Methods and Results We conducted a prospective study of 5218 older women with CVD who reported their blood pressure at baseline in the Womens Antioxidant Cardiovascular Study (WACS), an ongoing double-blind, placebo-controlled secondary prevention trial of the benefits and risks of antioxidant vitamins, folic acid, vitamin B6, and vitamin B12 among women with CVD or
3 coronary risk factors. A total of 661 confirmed CVD events (nonfatal myocardial infarction, nonfatal stroke, coronary artery bypass graft procedure, percutaneous coronary angioplasty, or CVD death) occurred during a median follow-up of 6.5 years. After controlling for age, randomized treatment assignment, antihypertensive medication use, and coronary risk factors, we found that systolic blood pressure (SBP) was a strong predictor of CVD events and that the relation between SBP and CVD risk was positive, continuous, and linear (P for linear trend=0.001). For each 10-mm Hg increment in SBP, there was a 9% (95% CI 4% to 15%) increase in risk of secondary CVD events. Diastolic blood pressure, mean arterial pressure, and pulse pressure were weaker predictors of CVD risk in this cohort, and joint consideration of SBP and diastolic blood pressure found that only SBP significantly predicted risk. Use of antihypertensive medication did not modify the relationship of SBP with CVD events.
Conclusions In this population of women with CVD, we observed a strong, continuous, and linear association between SBP and risk of secondary CVD events. SBP was the blood pressure measure most strongly related to CVD risk.
Key Words: hypertension cardiovascular diseases prevention women
This article has been cited by other articles:
![]() |
L. A. Bazzano, K. Reynolds, K. N. Holder, and J. He Effect of Folic Acid Supplementation on Risk of Cardiovascular Diseases: A Meta-analysis of Randomized Controlled Trials JAMA, December 13, 2006; 296(22): 2720 - 2726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Barlow, M. J. LaMonte, S. J. FitzGerald, J. B. Kampert, J. L. Perrin, and S. N. Blair Cardiorespiratory Fitness Is an Independent Predictor of Hypertension Incidence among Initially Normotensive Healthy Women Am. J. Epidemiol., January 15, 2006; 163(2): 142 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. SoRelle Cardiovascular News Circulation, April 6, 2004; 109(13): e9033 - e9034. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |